Openwater develops a healthcare platform that integrates infrared imaging, ultrasound, and electromagnetic fields to visualize, monitor, and treat biological issues at the cellular level. Its technology can selectively destroy cancer cells while leaving healthy cells unaffected. The company applies open-source principles and consumer electronics manufacturing to reduce medical device development time and costs. Openwater collaborates with institutions including UCLA, the University of Arizona, the University of Pennsylvania, and Brown University to validate its technology across multiple medical fields. Led by CEO Mary Lou Jepsen and based in Newark, CA, the company has raised $100M in total funding and plans to use the proceeds to expand operations and its business reach.

Total raised

$100M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2024